BÜCHLER, Tomáš, Marta KREJČÍ, A. SVOBODNÍK, Zdeněk ADAM, J. MINAŘÍK, J. BAČOVSKÝ, V. ŠČUDLA, Jiří MAYER, Jiří VORLÍČEK a Roman HÁJEK. Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy. The hematology journal. England: Nature Publishing Group, 2005, roč. 5, č. 7, s. 559-564. ISSN 1466-4860. |
Další formáty:
BibTeX
LaTeX
RIS
@article{837912, author = {Büchler, Tomáš and Krejčí, Marta and Svobodník, A. and Adam, Zdeněk and Minařík, J. and Bačovský, J. and Ščudla, V. and Mayer, Jiří and Vorlíček, Jiří and Hájek, Roman}, article_location = {England}, article_number = {7}, keywords = {multiple myeloma; hypertension; angiotensin-1-converting enzyme}, language = {eng}, issn = {1466-4860}, journal = {The hematology journal}, title = {Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy.}, volume = {5}, year = {2005} }
TY - JOUR ID - 837912 AU - Büchler, Tomáš - Krejčí, Marta - Svobodník, A. - Adam, Zdeněk - Minařík, J. - Bačovský, J. - Ščudla, V. - Mayer, Jiří - Vorlíček, Jiří - Hájek, Roman PY - 2005 TI - Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy. JF - The hematology journal VL - 5 IS - 7 SP - 559-564 EP - 559-564 PB - Nature Publishing Group SN - 14664860 KW - multiple myeloma KW - hypertension KW - angiotensin-1-converting enzyme N2 - In a retrospective study we have sought to determine whether the administration of angiotensin-I-converting enzyme inhibitors (ACEI) influences the outcome of patients with multiple myeloma (MM). Patients with MM who underwent autologous peripheral blood stem cell transplantation (PBSCT) (n=168) were studied. Patients taking ACEI alone or in combination with other antihypertensive agents during the hospital admission for PBSCT were allocated to the ACEI group (n=25; 15%). In conclusion, according to our findings, ACEI administered during PBSCT have adverse effect on survival of patients with MM. ER -
BÜCHLER, Tomáš, Marta KREJČÍ, A. SVOBODNÍK, Zdeněk ADAM, J. MINAŘÍK, J. BAČOVSKÝ, V. ŠČUDLA, Jiří MAYER, Jiří VORLÍČEK a Roman HÁJEK. Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy. \textit{The hematology journal}. England: Nature Publishing Group, 2005, roč.~5, č.~7, s.~559-564. ISSN~1466-4860.
|